SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-05-205097
Filing Date
2005-10-20
Accepted
2005-10-20 17:06:23
Documents
7
Period of Report
2005-10-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 27284
2 AMENDMENT AND RESTATEMENT OF RETIREMENT AND SAVINGS PLAN dex101.htm EX-10.1 366581
3 FIRST AMENDMENT TO THE DEFERRED COMPENSATION PLAN dex102.htm EX-10.2 15879
4 FIRST AMENDMENT TO THE SUPPLEMENTAL RETIREMENT PLAN dex103.htm EX-10.3 3644
5 FORMS OF THE AMENDED AND RESTATED STOCK OPTION GRANT AGREEMENTS dex104.htm EX-10.4 71612
6 FORMS OF THE AMENDED AND RESTATED STOCK OPTION GRANT AGREEMENTS dex105.htm EX-10.5 71940
7 FORMS OF THE AMENDED AND RESTATED STOCK OPTION GRANT AGREEMENTS dex106.htm EX-10.6 47431
  Complete submission text file 0001193125-05-205097.txt   606012
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 27-3-C THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320-1799 805-447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 051147877
SIC: 2836 Biological Products, (No Diagnostic Substances)